Indivior (INDV) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026

Indivior · Health Care · ref. ETF XLV · 16 calls · price $35.3

🏆JPI 2026 portfoliosSee tracking →

What the company does: Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

📈 Indivior (INDV) stock price

$35.3+47.8% over range

Aug 28, 25low $22.51 · high $41.83Aug 27, 26

📏 Click 2 points (left → right) to measure the change · click again to clear.

SellBuy

Buy

100% recommend buying · 1 analysts

📊 JPI status : Indivior has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 INDV price target & analyst consensus — price $35.30

The price target · all analysts combined (1 targets)

Highest target · 1 firm of 1$43+21.8%

Median target · of 1 targets$43+21.8%

Lowest target · 1 firm of 1$43+21.8%

Current price$35.3

⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 1 ratings (last 6 months)

Strong Buy00%

Buy1100%

Hold00%

Sell00%

Strong Sell00%

Go deeper on the analysts

🎯 INDV price target all

All 16 calls, one by one, with our verdict on each firm.

→ See all 16 targets, analyst by analyst

💡 The best analysts on INDV most reliable

Their real reliability on INDV, firm by firm: who was right, who was wrong.

→ See their reliability on INDV

All analysts (the consensus) · vs · the best (those who've been right)

💬 A question about Indivior? The JPI assistant answers using our backtest data.

🏛️ Indivior insider buying: who's buying and how much › open the full page

2 insiders bought3 buys / 6 mo $138k👥 Cluster buy

🔎 Detailed analyses

📊 Returns & performance 🏛️ Insider buying

✅ Historical analyst reliability on INDV

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕	% right i ↕	Gain vs sector i ↕	Calls i ↕
Piper Sandler ↗	100%	+160.6%	5
Craig-Hallum ↗	75%	+89.9%	4

📊 What $1,000 invested in Indivior would be worth › open the full page

In short — $1,000 invested in Indivior 10 years ago would be worth $2,958 today, i.e. +11%/yr on average. Best year: 2025 (+189%), worst: 2018 (-75%). Price performance, excluding dividends.

If I'd invested $1,000 in Indivior

Investment	Worth today	Gain
1 years ago	$3,237	+224%
3 years ago	$1,850	+85%
5 years ago	$5,492	+449%

→ See Indivior's full return history + gain calculator

Return by year (Indivior)

Year	Return	$1,000 invested at year start
2026 (YTD)	+12%	$1,121 (+12%)
2025	+189%	$3,237 (+224%)
2024	-19%	$2,635 (+163%)

→ See Indivior's full return history + gain calculator

⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Indivior

Loading news…

📋 All analyst calls on INDV

Barclays ↗

Aug 5, 26

▲ Overweight · 🎯$43

Price at call : $38.73 — upside +11%

Today : $35.3 — upside +22%

🎯 on INDV : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)

in progress (365j)
matures : Aug 5, 27

Barclays ↗

Jun 18, 26

▲ Overweight · 🎯$46

Price at call : $38.3 — upside +20%

Today : $35.3 — upside +30%

🎯 on INDV : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)

in progress (365j)
matures : Jun 18, 27

HC Wainwright & Co. ↗

Jan 12, 26

▲ Buy · 🎯$48

Price at call : $34.56 — upside +39%

Today : $35.3 — upside +36%

🎯 on INDV : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)

in progress (365j)
matures : Jan 12, 27

Piper Sandler ↗

Oct 31, 25

▲ Overweight · 🎯$41

Price at call : $31.2 — upside +31%

Today : $35.3 — upside +16%

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

in progress (365j)
matures : Oct 31, 26

HC Wainwright & Co. ↗

Oct 30, 25

▲ Buy · 🎯$35

Price at call : $29.37 — upside +19%

Today : $35.3 — upside -1%

🎯 on INDV : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)

in progress (365j)
matures : Oct 30, 26

Craig-Hallum ↗

Aug 27, 25

▲ Buy · 🎯$34

Price at call : $23.88 — upside +42%

Today : $35.3 — upside -4%

🎯 on INDV : 75% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)

in progress (365j)
matures : Aug 27, 26

HC Wainwright & Co. ↗

Aug 6, 25

▲ Buy · 🎯$28

Price at call : $22 — upside +27%

Today : $35.3 — upside -21%

Expected +27% · Actual +76% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)

+75.8%

stock +76% · XLV +26%

matured Aug 6, 26

Craig-Hallum ↗

Jun 30, 25

▲ Buy · 🎯$22

Price at call : $14.74 — upside +49%

Today : $35.3 — upside -38%

Expected +49% · Actual +178% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 75% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)

+178.4%

stock +178% · XLV +18%

matured Jun 30, 26

See the other 8 calls, newest to oldest

Piper Sandler ↗

Mar 6, 25

▲ Overweight · 🎯$13

Price at call : $9.89 — upside +31%

Today : $35.3 — upside -63%

Expected +31% · Actual +226% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

+226.3%

stock +226% · XLV +2%

matured Mar 6, 26

Piper Sandler ↗

Oct 25, 24

▲ Overweight · 🎯$16

Price at call : $8.92 — upside +79%

Today : $35.3 — upside -55%

Expected +79% · Actual +178% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

+177.8%

stock +178% · XLV -2%

matured Oct 25, 25

Craig-Hallum ↗

Oct 11, 24

▲ Buy · 🎯$16

Price at call : $7.9 — upside +103%

Today : $35.3 — upside -55%

Expected +103% · Actual +202% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 75% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)

+202.2%

stock +202% · XLV -8%

matured Oct 11, 25

Piper Sandler ↗

Oct 11, 24

▲ Overweight · 🎯$15

Price at call : $7.9 — upside +90%

Today : $35.3 — upside -58%

Expected +90% · Actual +202% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

+202.2%

stock +202% · XLV -8%

matured Oct 11, 25

Piper Sandler ↗

Sep 13, 24

▲ Overweight · 🎯$22

Price at call : $9.54 — upside +131%

Today : $35.3 — upside -38%

Expected +131% · Actual +143% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

+143.1%

stock +143% · XLV -13%

matured Sep 13, 25

Piper Sandler ↗

Jul 23, 24

▲ Overweight · 🎯$22

Price at call : $11.02 — upside +100%

Today : $35.3 — upside -38%

Expected +100% · Actual +54% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 100% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)

+53.8%

stock +54% · XLV -8%

matured Jul 23, 25

Craig-Hallum ↗

Jul 10, 24

▲ Buy · 🎯$24

Price at call : $11.33 — upside +112%

Today : $35.3 — upside -32%

Expected +112% · Actual +37% · Reason (≥ +15%) : ✓ Yes

🎯 on INDV : 75% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)

+36.5%

stock +37% · XLV -8%

matured Jul 10, 25

Craig-Hallum ↗

Apr 3, 24

▲ Buy · 🎯$37

Price at call : $21.43 — upside +73%

Today : $35.3 — upside +5%

Expected +73% · Actual -57% · Reason (≥ +15%) : ✗ No

🎯 on INDV : 75% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)

-57.3%

stock -57% · XLV -5%

matured Apr 3, 25

Frequently asked questions

Should I buy Indivior stock?

This isn't buy advice. For Indivior, the analyst consensus is "Buy", with an average price target of $43.00 (+22% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Indivior). We show the numbers — you decide.

Is it too late to buy Indivior? How high can it go?

The most bullish analyst target on Indivior is $43.00 (+22% above today's price); the average is $43.00. That's the upside they see. Check how reliable those analysts have actually been on Indivior on our site before trusting it.

Is Indivior still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 2 analysts have a real record on Indivior, the best hitting 100% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.

What has Indivior's past performance been?

Historical returns and a "how much if I had invested" calculator: INDV performance & returns.

Are insiders buying INDV stock?

Executives' and large holders' buys and sells, decoded: insider buying on INDV.